BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $108.22 million. The enterprise value is -$793,425.

Market Cap	108.22M
Enterprise Value	-793,425

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 48.10 million shares outstanding. The number of shares has increased by 22.74% in one year.

Shares Outstanding	48.10M
Shares Change (YoY)	+22.74%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	9.68%
Owned by Institutions (%)	64.47%
Float	33.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.53
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.03.

Current Ratio	4.11
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.60% and return on invested capital (ROIC) is -177.33%.

Return on Equity (ROE)	-110.60%
Return on Assets (ROA)	-75.40%
Return on Capital (ROIC)	-177.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.90M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.40% in the last 52 weeks. The beta is 1.06, so BioAtla's price volatility has been similar to the market average.

Beta (1Y)	1.06
52-Week Price Change	-34.40%
50-Day Moving Average	2.78
200-Day Moving Average	2.31
Relative Strength Index (RSI)	37.41
Average Volume (30 Days)	545,687

Short Selling Information

The latest short interest is 5.42 million, so 11.26% of the outstanding shares have been sold short.

Short Interest	5.42M
Short Previous Month	5.59M
Short % of Shares Out	11.26%
Short % of Float	16.00%
Short Ratio (days to cover)	7.48

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-129.69M
Pretax Income	-123.46M
Net Income	-123.46M
EBITDA	-122.24M
EBIT	-123.46M
Earnings Per Share (EPS)	-$2.58

Full Income Statement

Balance Sheet

The company has $111.47 million in cash and $2.46 million in debt, giving a net cash position of $109.01 million or $2.27 per share.

Cash & Cash Equivalents	111.47M
Total Debt	2.46M
Net Cash	109.01M
Net Cash Per Share	$2.27
Equity / Book Value	70.67M
Book Value Per Share	1.47
Working Capital	88.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$104.02 million and capital expenditures -$98,000, giving a free cash flow of -$104.11 million.

Operating Cash Flow	-104.02M
Capital Expenditures	-98,000
Free Cash Flow	-104.11M
FCF Per Share	-$2.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.74%
Shareholder Yield	-22.74%
Earnings Yield	-114.09%
FCF Yield	-96.21%

Analyst Forecast

The average price target for BioAtla is $14.50, which is 544.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.50
Price Target Difference	544.44%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2